# Dilaudid

NDC: 76045-121
Generic name: Hydromorphone hydrochloride
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20161216

FDA application: NDA019034

## Active ingredients

- HYDROMORPHONE HYDROCHLORIDE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76045-121"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76045-121
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9eebd88a-5632-460f-b7b6-26c8a180540d